Analytical Data
-
Gene name
SLC43A2
- Application
-
Alternative Names
(L-type amino acid transporter 4)(Solute carrier family 43 member 2)
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N370
-
Expression Region
224-322aa
-
Molecular Weight
15.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC43A2, also known as the solute carrier family 43 member 2, is a recently identified gene that plays a crucial role in the transport of certain amino acids, particularly in the context of cell metabolism and physiology. It has garnered attention in research due to its implications in various physiological processes, including neurotransmitter regulation, immune response, and cellular stress management. Additionally, studies have indicated that SLC43A2 may be associated with certain diseases, such as cancer and neurodegenerative disorders, where altered amino acid transport could contribute to pathological conditions. The recombinant protein of SLC43A2 is essential for elucidating its functional mechanisms in these processes. By generating and characterizing the SLC43A2 recombinant protein, researchers aim to investigate its transport activity, structural properties, and interaction with other biomolecules. This research could pave the way for understanding the molecular basis of diseases linked to amino acid transport dysregulation and may lead to the development of new therapeutic strategies targeting these pathways. Overall, the study of SLC43A2 recombinant protein holds significant promise for advancing our knowledge in cellular biology and addressing health-related challenges linked to this important transporter.
